Acadia Pharma (ACAD) on Watch Amid rumors of Allergan (AGN) Interest

September 28, 2016 1:04 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

(Updated)

Acadia Pharma (Nasdaq: ACAD) was in focus Wednesday on reports it could attract interest from Allergan (NYSE: AGN). DealReporter was the source of today's speculation.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment